Oxycodone Drug Market 2019-2025
|出版商||Orion Market Research Pvt Ltd||商品编码||949574|
|羟考酮医药品市场:2019-2025年 Oxycodone Drug Market 2019-2025|
|出版日期: 2020年06月12日||内容资讯: 英文||
Global Oxycodone Drug Market Size, Share & Trends Analysis Report, by Applications (Pain Management, Anesthesia, and Addiction Management), and Forecast Period 2019-2025
The global oxycodone drug market is estimated to grow at a significant CAGR during the forecast period. The increasing frequency of terminally ill diseases such as cancer and HIV and a high surge in post-operative pain prescribed medication is driving the growth of the global oxycodone drug market.New drug development is a large market opportunity for the oxycodone market. New products with innovations in formulations and drug designing such as abuse-deterrent formulations done in Oxycontin and Opana, fuel the branded opiate market. Moreover, the US Food and Drug Administration is also encouraging drug makers to come up with a new generation drug that is less addictive.
An increase in new drug applications by pharmaceutical companies and the number of products in the pipeline drives the future opportunity growth of the global oxycodone market. Other formulations such as control release of drugs for improved pain management are coming up in the market. Advanced drug formulations such as extended-release medications for pain control are examples of improved formulation driving the market.
The global oxycodone market is segmented into applications into pain management, anesthesia, and de-addiction. Pain management accounts for the largest market portion, owing to the increasing frequency of Parkinson's syndrome, rheumatic, and cancer patients. Geographically, theglobal oxycodone drugs market is segmented based on the region including North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
The major manufactures of the oxycodone drug include Purdue Pharma L.P, Janssen Pharmaceuticals (A Johnson & Johnson Subsidiary), Inc., Hikma Pharmaceuticals USA, Inc., Pfizer, Inc., Sanofi-Aventis S.A., Sun Pharmaceutical Industries Ltd., and others. The range of oxycodone drugs provided by these companies is Oxynorm, OxyContin, Endone, Proladone, Targin, and more. These companies are receiving approvals for new drugs that are expected to contribute to the oxycodone drug market. For instance, in April 2017, the FDA approved RoxyBond, a new formulation of immediate-release oxycodone. This oxycodone formulation is the first immediate-release opioid analgesic approved with labeling describing its abuse-deterrent properties.
The market study of the global oxycodone drugs market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
The report is intended for providers, suppliers, and distributors of fiberglass, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market.
The Report Covers: